Haemophilus Influenzae Type B Capsular Polysaccharide Meningococcal Outer Membrane Protein Conjugate Antigen Liquid
FDA Label NDC 69806-0001

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Merck Sharp & Dohme Corp. for the product Haemophilus Influenzae Type B Capsular Polysaccharide Meningococcal Outer Membrane Protein Conjugate Antigen (NDC 69806-0001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding principal display panel - shipping label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Principal Display Panel - Shipping Label

H. INFLUENZAE TYPEB CONJ HIB
MRKPRP EU

V.1356.29.0002

Material: 2009322
Batch: 0000468304
Qty:

Rx only. Caution: For manufacturing, processing, or repacking
Storage: (2 °C)-(8 °C)

WEST POINT Mfg. WEST POINT PA 19486-8000 US 215-652-6100

US Gov't Lic No. 0002

MERCK

Shipping Label (Haemophilus 01)

Shipping Label (Haemophilus 01)

* Please review the disclaimer below.